160 related articles for article (PubMed ID: 25330855)
1. Emerging drugs for endometrial cancer.
Amadio G; Masciullo V; Ferrandina MG; Scambia G
Expert Opin Emerg Drugs; 2014 Dec; 19(4):497-509. PubMed ID: 25330855
[TBL] [Abstract][Full Text] [Related]
2. Molecular targets and targeted therapeutics in endometrial cancer.
Weigelt B; Banerjee S
Curr Opin Oncol; 2012 Sep; 24(5):554-63. PubMed ID: 22581357
[TBL] [Abstract][Full Text] [Related]
3. Recent and current Phase II clinical trials in endometrial cancer: review of the state of art.
Lheureux S; Wilson M; Mackay HJ
Expert Opin Investig Drugs; 2014 Jun; 23(6):773-92. PubMed ID: 24717108
[TBL] [Abstract][Full Text] [Related]
4. Bevacizumab in endometrial cancer treatment.
Morotti M; Valenzano Menada M; Venturini PL; Ferrero S
Expert Opin Biol Ther; 2012 May; 12(5):649-58. PubMed ID: 22428875
[TBL] [Abstract][Full Text] [Related]
5. [The validity of chemotherapy in the treatment of endometrial cancer].
Fehr MK; Streich MS
Gynakol Geburtshilfliche Rundsch; 2006; 46(1-2):34-8. PubMed ID: 16452818
[TBL] [Abstract][Full Text] [Related]
6. Systemic therapy in metastatic or recurrent endometrial cancer.
Pectasides D; Pectasides E; Economopoulos T
Cancer Treat Rev; 2007 Apr; 33(2):177-90. PubMed ID: 17196749
[TBL] [Abstract][Full Text] [Related]
7. An update on the current pharmacotherapy for endometrial cancer.
de Haydu C; Black JD; Schwab CL; English DP; Santin AD
Expert Opin Pharmacother; 2016; 17(4):489-99. PubMed ID: 26629895
[TBL] [Abstract][Full Text] [Related]
8. Endometrial cancer: redefining the molecular-targeted approach.
Silva JL; Paulino E; Dias MF; Melo AC
Cancer Chemother Pharmacol; 2015 Jul; 76(1):1-11. PubMed ID: 25935126
[TBL] [Abstract][Full Text] [Related]
9. Advances in the approach to novel drug clinical development for breast cancer.
Ferrario C; Batist G
Expert Opin Drug Discov; 2014 Jun; 9(6):647-68. PubMed ID: 24758225
[TBL] [Abstract][Full Text] [Related]
10. Endometrial cancer: Molecular markers and management of advanced stage disease.
Arend RC; Jones BA; Martinez A; Goodfellow P
Gynecol Oncol; 2018 Sep; 150(3):569-580. PubMed ID: 29843906
[TBL] [Abstract][Full Text] [Related]
11. Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies.
Gadducci A; Cosio S; Genazzani AR
Crit Rev Oncol Hematol; 2006 Jun; 58(3):242-56. PubMed ID: 16436330
[TBL] [Abstract][Full Text] [Related]
12. Novel targeted therapies for the treatment of penile cancer.
Agarwal G; Gupta S; Spiess PE
Expert Opin Drug Discov; 2014 Aug; 9(8):959-68. PubMed ID: 24896220
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy in endometrial carcinoma: overview of randomised trials.
Hogberg T
Clin Oncol (R Coll Radiol); 2008 Aug; 20(6):463-9. PubMed ID: 18467080
[TBL] [Abstract][Full Text] [Related]
14. Targeting fibroblast growth factor pathways in endometrial cancer.
Winterhoff B; Konecny GE
Curr Probl Cancer; 2017; 41(1):37-47. PubMed ID: 28041631
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic targeting of the TNF superfamily: a promising treatment for advanced endometrial adenocarcinoma.
Thangaraju S; Subramani E; Chakravarty B; Chaudhury K
Gynecol Oncol; 2012 Nov; 127(2):426-32. PubMed ID: 22885470
[TBL] [Abstract][Full Text] [Related]
16. Emerging drugs in endometrial cancers.
Altundag O; Dursun P; Ayhan A
Expert Opin Emerg Drugs; 2010 Dec; 15(4):557-68. PubMed ID: 20828226
[TBL] [Abstract][Full Text] [Related]
17. Developments in the systemic treatment of endometrial cancer.
Mountzios G; Pectasides D; Bournakis E; Pectasides E; Bozas G; Dimopoulos MA; Papadimitriou CA
Crit Rev Oncol Hematol; 2011 Sep; 79(3):278-92. PubMed ID: 20833559
[TBL] [Abstract][Full Text] [Related]
18. Update on the chemotherapeutic management of endometrial cancer.
Bregar A; Robison K; Dizon DS
Clin Adv Hematol Oncol; 2014 Oct; 12(10):659-65. PubMed ID: 25658891
[TBL] [Abstract][Full Text] [Related]
19. Randomized evidence on chemotherapy and hormonal therapy regimens for advanced endometrial cancer: an overview of survival data.
Polyzos NP; Pavlidis N; Paraskevaidis E; Ioannidis JP
Eur J Cancer; 2006 Feb; 42(3):319-26. PubMed ID: 16376072
[TBL] [Abstract][Full Text] [Related]
20. Emerging drugs in metastatic breast cancer: an update.
Arslan C; Altundag K; Dizdar O
Expert Opin Emerg Drugs; 2011 Dec; 16(4):647-67. PubMed ID: 22122529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
